Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Catherine, Cailleau"'
Autor:
Romain Brusini, Natalie Lan Linh Tran, Catherine Cailleau, Valérie Domergue, Valérie Nicolas, Flavio Dormont, Serge Calet, Caroline Cajot, Albin Jouran, Sinda Lepetre-Mouelhi, Julie Laloy, Patrick Couvreur, Mariana Varna
Publikováno v:
Pharmaceutics, Vol 15, Iss 7, p 1790 (2023)
Reperfusion injuries after a period of cardiac ischemia are known to lead to pathological modifications or even death. Among the different therapeutic options proposed, adenosine, a small molecule with platelet anti-aggregate and anti-inflammatory pr
Externí odkaz:
https://doaj.org/article/51b5c206bd4e446d9ced361c561529a2
Autor:
Raul Diaz-Salmeron, Balthazar Toussaint, Catherine Cailleau, Gilles Ponchel, Kawthar Bouchemal
Publikováno v:
Advanced NanoBiomed Research, Vol 2, Iss 5, Pp n/a-n/a (2022)
Intravesical instillation allows for direct exposure of the urothelium to a drug. However, the therapeutic efficacy is often limited by the rapid elimination of the drug from the bladder. In this investigation, it is hypothesized that the morphology
Externí odkaz:
https://doaj.org/article/720531a436c544c0ab1f907acca7df58
Autor:
Zhibo Yu, Nicolas Tsapis, François Fay, Liang Chen, Andrii Karpus, Xiangyang Shi, Catherine Cailleau, Samuel García Pérez, Nicolas Huang, Juliette Vergnaud, Serge Mignani, Jean-Pierre Majoral, Elias Fattal
Publikováno v:
Biomacromolecules. 24:667-677
Small interfering RNA (siRNA) holds promise for treating rheumatoid arthritis by inhibiting major cytokines such as tumor necrosis factor-α (TNF-α). We developed original cationic amphiphilic phosphorus dendrons to produce dendriplexes associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3021734da253dd8f896b6dd158be2809
https://doi.org/10.1021/acs.biomac.2c01117
https://doi.org/10.1021/acs.biomac.2c01117
Autor:
Kamila Bohne Japiassu, Francois Fay, Alessandro Marengo, Younès Louaguenouni, Catherine Cailleau, Stéphanie Denis, David Chapron, Nicolas Tsapis, Thais Leite Nascimento, Eliana Martins Lima, Elias Fattal
Publikováno v:
Journal of Controlled Release. 352:15-24
Alveolar macrophages play a crucial role in the initiation and resolution of the immune response in the lungs. Pro-inflammatory M1 alveolar macrophages are an interesting target for treating inflammatory and infectious pulmonary diseases. One commune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09d0859cb79154c9fdbf501104883aaa
https://doi.org/10.1016/j.jconrel.2022.10.006
https://doi.org/10.1016/j.jconrel.2022.10.006
Autor:
Varna, Romain Brusini, Natalie Lan Linh Tran, Catherine Cailleau, Valérie Domergue, Valérie Nicolas, Flavio Dormont, Serge Calet, Caroline Cajot, Albin Jouran, Sinda Lepetre-Mouelhi, Julie Laloy, Patrick Couvreur, Mariana
Publikováno v:
Pharmaceutics; Volume 15; Issue 7; Pages: 1790
Reperfusion injuries after a period of cardiac ischemia are known to lead to pathological modifications or even death. Among the different therapeutic options proposed, adenosine, a small molecule with platelet anti-aggregate and anti-inflammatory pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::f74460645b785fb538dbd52b8956fd0f
Autor:
Alexandre Bordat, Tanguy Boissenot, Nada Ibrahim, Marianne Ferrere, Manon Levêque, Léa Potiron, Stéphanie Denis, Sébastien Garcia-Argote, Olivia Carvalho, Jérôme Abadie, Catherine Cailleau, Grégory Pieters, Nicolas Tsapis, Julien Nicolas
Publikováno v:
Journal of the American Chemical Society
Journal of the American Chemical Society, 2022, 144 (41), pp.18844-18860. ⟨10.1021/jacs.2c04944⟩
Journal of the American Chemical Society, 2022, 144 (41), pp.18844-18860. ⟨10.1021/jacs.2c04944⟩
International audience; Chemotherapy is almost exclusively administered via the intravenous (IV) route, which has serious limitations (e.g., patient discomfort, long hospital stays, need for trained staff, high cost, catheter failures, infections). T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11d371ca42e8c4ee924ece56d0768e6c
https://hal.science/hal-03805373/document
https://hal.science/hal-03805373/document
Autor:
Jean-Baptiste, Bodin, Jérôme, Gateau, Justine, Coïs, Théotim, Lucas, Flora, Lefebvre, Laurence, Moine, Magali, Noiray, Catherine, Cailleau, Stéphanie, Denis, Gilles, Clavier, Nicolas, Tsapis, Rachel, Méallet-Renault
Publikováno v:
ACS applied materialsinterfaces. 14(36)
We have designed a new Bodipy scaffold for efficient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fc75531fbb1a098cd5a6082af889c013
https://pubmed.ncbi.nlm.nih.gov/36044427
https://pubmed.ncbi.nlm.nih.gov/36044427
Autor:
Kamila Bohne Japiassu, Francois Fay, Alessandro Marengo, Sebastião A. Mendanha, Catherine Cailleau, Younès Louaguenouni, Qinglin Wang, Stéphanie Denis, Nicolas Tsapis, Thais Leite Nascimento, Eliana Martins Lima, Elias Fattal
Publikováno v:
International Journal of Pharmaceutics. 639:122946
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43158f360164f7d102079d7c8b494f2e
https://doi.org/10.1016/j.ijpharm.2023.122946
https://doi.org/10.1016/j.ijpharm.2023.122946
Autor:
Antonio Lipa Castro, Sébastien Pomel, Catherine Cailleau, Natalie Fournier, Indira Dennemont, Philippe M. Loiseau, Gillian Barratt
Publikováno v:
International journal of pharmaceutics. 624
Amphotericin B (AmB) is an effective drug to treat visceral leishmaniasis but its use is limited by its poor oral bioavailability. This article describes the in-vivo evaluation of AmB-loaded, lipid-based cochleate systems designed for the oral route.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21cdeaa08d1ab617ffce6bdde956cd4d
https://pubmed.ncbi.nlm.nih.gov/35820519
https://pubmed.ncbi.nlm.nih.gov/35820519
Autor:
Alexandre Bordat, Tanguy Boissenot, Nada Ibrahim, Marianne Ferrere, Manon Levêque, Stéphanie Denis, Sébastien Garcia-Argote, Olivia Carvalho, Jérôme Abadie, Catherine Cailleau, Gregory Pieters, Nicolas Tsapis, Julien Nicolas
Chemotherapy is almost exclusively administered via the intravenous (IV) route, which has serious limitations (e.g., patient discomfort, long hospital stays, need for trained staff, high cost, catheter failures, infections). Therefore, the developmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b54a3f69caeac90c5887a0d10104a2d
https://doi.org/10.26434/chemrxiv-2021-h0cwv-v2
https://doi.org/10.26434/chemrxiv-2021-h0cwv-v2